05 February 2014

Role of Specific Pulmonary Vasodilator Therapy in PH Due to Left Heart Disease

All credit to Nedim Selimovic, Senior Consultant, Cardiology/Heart transplantation, King Faisal Specialist Hospital & Research Centre Riyadh | Saudi Arabia

Presented at 7th Annual Joint Pulmonary Hypertension Assembly, SAPH2014, May 1-3 2014, Muscat, Oman

 

Additional key-words:  vasoreactivity, left heart disease, DILATE-1

Our research platform is the world.

Through worldwide collaboration, we can begin to answer the question of a global disease.

Join the PVRI
standard-example-image.jpg